Search Results - "MEGGIATO, T"

PO.15 PREVENTION AND EARLY DIAGNOSIS OF COLORECTAL CANCER WITH ENDOSCOPY: WHAT IS USEFUL? by Polato, F, Lobello, S, Meggiato, T, Gavaruzzi, T, Lotto, L, De Lazzari, F

Get full text

Spontaneous apoptosis and proliferation in human pancreatic cancer by MEGGIATO, T, CALABRESE, F, VALENTE, M, FAVARETTO, E, BALIELLO, E, DEL FAVERO, G

“…Several studies have documented the role of programmed cell death in the development and/or progression of cancer. The aims of this study were to analyze (a)…”
Get full text

Ki-67 and c-jun expression in pancreatic cancer: a prognostic marker? by Ferrara, C, Tessari, G, Poletti, A, Giacon, C, Meggiato, T, Martines, D, Del Favero, G, Naccarato, R

“…The proto-oncogene c-jun is involved in cell proliferation and Ki-67 antigen permits determination of the proportion of proliferating tumour cells. The…”
Get more information

Management of malignant colonic polyps (T1). Endoscopic polypectomy vs surgery and analysis of pathological risk factors for lymph node metastasis: A prospective monocentric study by Parini, D., Zuolo, M., Meggiato, T., Del Favero, G., Galeotti, F.

Get full text

Serum growth factors in patients with pancreatic cancer by Meggiato, T, Plebani, M, Basso, D, Panozzo, M P, Del Favero, G

“…The aims of this study were (1) to assess possible variations in the serum levels of epidermal growth factor (EGF), insulin-like growth factor I (IGF I) and…”
Get more information

Computed tomography in predicting gall stone solubility: a prospective trial by Caroli, A, Del Favero, G, Di Mario, F, Spigariol, F, Scalon, P, Meggiato, T, Zambelli, C, Naccarato, R

“…This prospective study was undertaken to evaluate the correlation between densitometric values of gall stones assessed by computed tomography and the success…”
Get full text

β-cell function in pancreatic adenocarcinoma by BASSO, D, PLEBANI, M, FOGAR, P, DEL FAVERO, G, BRIANI, G, MEGGIATO, T, PANOZZO, M. P, FERRARA, C, D'ANGELI, F, BURLINA, A

“…To evaluate beta-cell function in patients with pancreatic cancer, the glucagon stimulation test was performed in seven patients with pancreatic…”
Get full text

C-peptide pattern in patients with pancreatic cancer by Fogar, P, Basso, D, Panozzo, M P, Del Favero, G, Briani, G, Fabris, C, D'Angeli, F, Meggiato, T, Ferrara, C, Plebani, M

“…The pathogenetic mechanism underlying glucose intolerance in pancreatic cancer is still unclear. We studied the pattern of three glucose regulating hormones…”
Get more information

Extra-hepatic cholestasis determines a reversible increase of glycoproteic tumour markers in benign and malignant diseases by Basso, D, Meggiato, T, Fabris, C, Plebani, M, Fogar, P, Panozzo, M P, Del Favero, G

“…This study was performed in order to assess the relative role of cholestasis in increasing some serum glycoproteic markers of malignancy (CA 19-9, TPA, CEA)…”
Get more information

Re: Current treatment modalities for symptomatic gallstones by Del Favero, G, Di Mario, F, Meggiato, T, Scalon, P, Caroli, A

Get more information

Oxygen derived free radicals in patients with chronic pancreatic and other digestive diseases by Basso, D, Panozzo, M P, Fabris, C, del Favero, G, Meggiato, T, Fogar, P, Meani, A, Faggian, D, Plebani, M, Burlina, A

“…To ascertain modifications in the activation products derived from oxygen free radicals in patients with chronic pancreatic and extra-pancreatic diseases,…”
Get full text

Concanavalin A affinity pattern of CA 19-9: an in vitro and in vivo study by Basso, D, Panozzo, M P, Del Giudice, G, Carbone, M D, Meggiato, T, Del Favero, G, Plebani, M

Get more information

Serum DU-PAN-2 in the differential diagnosis of pancreatic cancer: influence of jaundice and liver dysfunction by FABRIS, C, MALESCI, A, SCALON, P, NACCARATO, R, BASSO, D, BONATO, C, DEL FAVERO, G, TACCONI, M, MEGGIATO, T, FOGAR, P, PANOZZO, M. P, FERRARA, C

“…The usefulness of serum DU-PAN-2 in diagnosing pancreatic cancer and in distinguishing between this cancer and other benign and malignant diseases, and to…”
Get full text

Does serum CAR-3 play a role in pancreatic cancer diagnosis? by Basso, D, Panozzo, M P, Fabris, C, Meggiato, T, Faggian, D, Fogar, P, Scalon, P, Del Favero, G, Plebani, M, Burlina, A

“…A new tumour marker, CAR-3, was isolated using the monoclonal antibody technique and measured in the sera of 27 patients with pancreatic cancer, 25 chronic…”
Get more information

Do CA 19-9 and TPA play a minor role as compared to AFP in diagnosing primary hepatocellular carcinoma? by Leandro, G, Zizzari, S, Fabris, C, Basso, D, Elba, S, Del Favero, G, Meggiato, T, Angonese, C, Di Mario, F, Manghisi, O G

“…This study was undertaken in order to compare the ability of 4 tumour markers to discriminate between liver cirrhosis patients with or without hepatocellular…”
Get more information

Tumour markers in gastrointestinal malignancies: an update by Del Favero, G, Farinati, F, Di Mario, F, Plebani, M, Basso, D, Valiante, F, Meggiato, T, Della Libera, G, Fabris, C, Fanton, M C

Get more information

Lipid peroxidation and renal tubular damage in chronic pancreatic diseases: is there any relationship? by Basso, D, Panozzo, M P, Plebani, M, Meggiato, T, Zaninotto, M, Piccoli, A, Fogar, P, Ferrara, C, Del Favero, G, Burlina, A

“…Lipid peroxidation is one of the most important expression of oxidative stress induced by oxygen-derived free radicals. Here we evaluate the behavior of…”
Get more information

Comparison of two newly identified tumor markers (CAR-3 and DU-PAN-2) with CA 19-9 in patients with pancreatic cancer by Ferrara, C, Basso, D, Fabris, C, Malesci, A, Fogar, P, Meggiato, T, Panozzo, M P, Scalon, P, Del Favero, G, Plebani, M

“…We compared the diagnostic utility of DU-PAN-2 and CAR-3 with that of CA 19-9 in differentiating pancreatic cancer (23 patients) from chronic pancreatitis (16…”
Get more information

Alterations in bilirubin metabolism during extra- and intrahepatic cholestasis by Basso, D, Fabris, C, Plebani, M, Del Favero, G, Muraca, M, Vilei, M T, Panozzo, M P, Meggiato, T, Fogar, P, Burlina, A

“…This study was performed to investigate modifications in the serum bilirubin forms, hepatobiliary enzymes, and some glycoproteic substances in patients during…”
Get full text

CAR-3 and CA 19-9 serum levels in pancreatic cancer: any differences between two epitopes of the same mucin-like glycoprotein? by Meggiato, T, Basso, D, Fabris, C, Fogar, P, Panozzo, M P, Plebani, M, Faggian, D, Scalon, P, Ferrara, C, Del Favero, G

“…The aim of this study was to compare the utility of two recently identified tumour markers of pancreatic cancer, CA 19-9 and CAR-3, and to ascertain the roles…”
Get more information